Nova Cannabis Inc.
NVACF · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.06 | 0.44 | -0.37 | 0.05 |
| FCF Yield | 1.10% | 2.00% | 8.92% | 11.06% |
| EV / EBITDA | 24.69 | 54.21 | 22.82 | 15.05 |
| Quality | ||||
| ROIC | 1.66% | 1.49% | 2.94% | 2.91% |
| Gross Margin | 20.09% | 20.21% | 21.19% | 25.11% |
| Cash Conversion Ratio | 1.78 | -8.41 | 11.34 | 2.66 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.76% | 16.68% | 24.51% | 60.12% |
| Free Cash Flow Growth | -62.16% | -55.38% | 4.54% | 90.43% |
| Safety | ||||
| Net Debt / EBITDA | 10.20 | 17.36 | 11.28 | 8.61 |
| Interest Coverage | 1.75 | 1.44 | 2.84 | 2.75 |
| Efficiency | ||||
| Inventory Turnover | 3.08 | 3.05 | 3.24 | 3.86 |
| Cash Conversion Cycle | 26.53 | 16.65 | 29.78 | 18.01 |